Unnamed: 0
int64 0
1.41M
| headline
stringlengths 3
513
| url
stringlengths 33
162
| publisher
stringlengths 3
46
| date
timestamp[s] | stock
stringlengths 1
5
|
|---|---|---|---|---|---|
1,412,421 | BMO Capital Upgrades Zoetis to Outperform | https://www.benzinga.com/news/15/09/5831528/bmo-capital-upgrades-zoetis-to-outperform | Paul Quintaro | 2015-09-11T00:00:00 | ZTS |
1,412,422 | Zoetis, HCA Holdings Shares Halted on Circuit Breaker | https://www.benzinga.com/movers/15/08/5786298/zoetis-hca-holdings-shares-halted-on-circuit-breaker | Paul Quintaro | 2015-08-24T00:00:00 | ZTS |
1,412,423 | A Look At Bill Ackman's Super-Concentrated Equity Portfolio | https://www.benzinga.com/general/biotech/15/08/5774817/a-look-at-bill-ackmans-super-concentrated-equity-portfolio | Javier Hasse | 2015-08-18T00:00:00 | ZTS |
1,412,424 | What Steven Cohen Did With His Wealth In Q2 | https://www.benzinga.com/trading-ideas/long-ideas/15/08/5771038/what-steven-cohen-did-with-his-wealth-in-q2 | Javier Hasse | 2015-08-17T00:00:00 | ZTS |
1,412,425 | William Blair Upgrades Zoetis to Outperform | https://www.benzinga.com/news/15/08/5741724/william-blair-upgrades-zoetis-to-outperform | Paul Quintaro | 2015-08-06T00:00:00 | ZTS |
1,412,426 | Evercore ISI's Mark Schoenebaum Comments On Zoetis' Q2 Call | https://www.benzinga.com/analyst-ratings/analyst-color/15/08/5733482/evercore-isis-mark-schoenebaum-comments-on-zoetis-q2-cal | Javier Hasse | 2015-08-04T00:00:00 | ZTS |
1,412,427 | Zoetis Reports Q2 Sales $1.2B vs $1.12B Est., Adj. EPS $0.43 vs $0.38 Est.; Sees FY15 Adj. EPS $1.63-$1.68 vs $1.66 Est. | https://www.benzinga.com/news/earnings/15/08/5731071/zoetis-reports-q2-sales-1-2b-vs-1-12b-est-adj-eps-0-43-vs-0-38-est-sees- | Paul Quintaro | 2015-08-04T00:00:00 | ZTS |
1,412,428 | Zoetis Given a Conditional License from USDA for Canine Atopic Dermatitis Immunotherapeutic | https://www.benzinga.com/news/15/08/5729658/zoetis-given-a-conditional-license-from-usda-for-canine-atopic-dermatitis-immunot | Hal Lindon | 2015-08-03T00:00:00 | ZTS |
1,412,429 | Option Alert: Zoetis Aug $49 Call Sweep; 1000 Contracts @Ask @$1.50; Now $47.97 | https://www.benzinga.com/news/15/07/5682124/option-alert-zoetis-aug-49-call-sweep-1000-contracts-ask-1-50 | Charles Gross | 2015-07-17T00:00:00 | ZTS |
1,412,430 | Canaccord Believes Zoetis Could Bid For Idexx Laboratories | https://www.benzinga.com/analyst-ratings/analyst-color/15/06/5631953/canaccord-believes-zoetis-could-bid-for-idexx-laboratori | Jayson Derrick | 2015-06-29T00:00:00 | ZTS |
1,412,431 | Canaccord Believes Zoetis Could Make A Bid For IDEXX, Sees IDXX Shares With Upside Potential Given Buyback Of $10M And CEO Stock Purchasing | https://www.benzinga.com/analyst-ratings/analyst-color/15/06/5631677/canaccord-believes-zoetis-could-make-a-bid-for-idexx-see | Eddie Staley | 2015-06-29T00:00:00 | ZTS |
1,412,432 | Benzinga's Weekend M&A Chatter | https://www.benzinga.com/media/cnbc/15/06/5630339/benzingas-weekend-m-a-chatter | Charles Gross | 2015-06-28T00:00:00 | ZTS |
1,412,433 | 10 Movers To Keep An Eye On This Week | https://www.benzinga.com/news/15/06/5629434/10-movers-to-keep-an-eye-on-this-week | Santhosh Naikar | 2015-06-28T00:00:00 | ZTS |
1,412,434 | Mid-Afternoon Market Update: US Stocks Mixed; Micron Technology Shares Fall On Downbeat Results | https://www.benzinga.com/news/earnings/15/06/5629141/mid-afternoon-market-update-us-stocks-mixed-micron-technology-shares-fal | Garrett Cook | 2015-06-26T00:00:00 | ZTS |
1,412,435 | Mid-Day Market Update: Nike Jumps On Strong Results; SYNNEX Shares Slide | https://www.benzinga.com/news/earnings/15/06/5628712/mid-day-market-update-nike-jumps-on-strong-results-synnex-shares-slide | Garrett Cook | 2015-06-26T00:00:00 | ZTS |
1,412,436 | BMO Downgrades Zoetis After Valeant Report | https://www.benzinga.com/analyst-ratings/analyst-color/15/06/5628688/bmo-downgrades-zoetis-after-valeant-report | Jim Swanson | 2015-06-26T00:00:00 | ZTS |
1,412,437 | Friday's Mid-Day Movers: Micron, Winnebago, Cleveland BioLabs And More | https://www.benzinga.com/news/15/06/5628539/fridays-mid-day-movers-micron-winnebago-cleveland-biolabs-and-more | Jon Kashat | 2015-06-26T00:00:00 | ZTS |
1,412,438 | Is Bill Ackman Playing Cupid In Valeant's Rumored Attempt To Woo Zoetis? | https://www.benzinga.com/analyst-ratings/analyst-color/15/06/5628437/is-bill-ackman-playing-cupid-in-valeants-rumored-attempt | Ritesh Anan | 2015-06-26T00:00:00 | ZTS |
1,412,439 | Mid-Morning Market Update: Markets Gain; Finish Line Beats Q1 Views | https://www.benzinga.com/news/earnings/15/06/5628476/mid-morning-market-update-markets-gain-finish-line-beats-q1-views | Garrett Cook | 2015-06-26T00:00:00 | ZTS |
1,412,440 | Valeant-Zoetis Combination Has 'Accretive' Upside | https://www.benzinga.com/analyst-ratings/analyst-color/15/06/5628207/valeant-zoetis-combination-has-accretive-upside | Monica Gerson | 2015-06-26T00:00:00 | ZTS |
1,412,441 | Morning Market Losers | https://www.benzinga.com/news/15/06/5628156/morning-market-losers | Lisa Levin | 2015-06-26T00:00:00 | ZTS |
1,412,442 | Zoetis Shares Pullback After Open; May be Attributed to Negative Comments by David Faber on CNBC | https://www.benzinga.com/media/cnbc/15/06/5628128/zoetis-shares-pullback-after-open-may-be-attributed-to-negative-comments-by | Charles Gross | 2015-06-26T00:00:00 | ZTS |
1,412,443 | US Stock Futures Rise Ahead Of Consumer Sentiment Report | https://www.benzinga.com/news/15/06/5627681/us-stock-futures-rise-ahead-of-consumer-sentiment-report | Monica Gerson | 2015-06-26T00:00:00 | ZTS |
1,412,444 | Zoetis Eyed For Acquisition By Valeant Pharmaceuticals | https://www.benzinga.com/news/15/06/5626425/zoetis-eyed-for-acquisition-by-valeant-pharmaceuticals | John Seward | 2015-06-26T00:00:00 | ZTS |
1,412,445 | Dan Nathan Sees Unusual Options Activity In Zoetis | https://www.benzinga.com/media/cnbc/15/06/5627093/dan-nathan-sees-unusual-options-activity-in-zoetis | Craig Jones | 2015-06-26T00:00:00 | ZTS |
1,412,446 | JP Morgan Comments on Potential Combination Of Valeant And Zoetis, Remains Overweight VRX and Neutral on ZTS | https://www.benzinga.com/analyst-ratings/analyst-color/15/06/5627491/jp-morgan-comments-on-potential-combination-of-valeant-a | Eddie Staley | 2015-06-26T00:00:00 | ZTS |
1,412,447 | Must Watch Stocks for Today | https://www.benzinga.com/news/earnings/15/06/5627393/must-watch-stocks-for-today | Monica Gerson | 2015-06-26T00:00:00 | ZTS |
1,412,448 | Benzinga's M&A Chatter for Thursday June 25, 2015 | https://www.benzinga.com/news/15/06/5626761/benzingas-m-a-chatter-for-thursday-june-25-2015 | Charles Gross | 2015-06-25T00:00:00 | ZTS |
1,412,449 | Valeant Made Preliminary Takeover Approach to Zoetis - Sources | https://www.benzinga.com/news/15/06/5626172/valeant-made-preliminary-takeover-approach-to-zoetis-sources | Charles Gross | 2015-06-25T00:00:00 | ZTS |
1,412,450 | Zoetis CEO Talks Animal Health At William Blair Growth Conference | https://www.benzinga.com/news/15/06/5587213/zoetis-ceo-talks-animal-health-at-william-blair-growth-conference | Wayne Duggan | 2015-06-11T00:00:00 | ZTS |
1,412,451 | Who's The Next Big Pharma Acquisition? | https://www.benzinga.com/analyst-ratings/analyst-color/15/05/5550476/whos-the-next-big-pharma-acquisition | Wayne Duggan | 2015-05-29T00:00:00 | ZTS |
1,412,452 | Stocks Hitting 52-Week Highs | https://www.benzinga.com/news/15/05/5552095/stocks-hitting-52-week-highs | Lisa Levin | 2015-05-29T00:00:00 | ZTS |
1,412,453 | Portfolio Manager Minyi Chen On Why Certain Companies Are Likely M&A Targets | https://www.benzinga.com/news/15/05/5516136/portfolio-manager-minyi-chen-on-why-certain-companies-are-likely-m-a-targets | Jim Probasco | 2015-05-18T00:00:00 | ZTS |
1,412,454 | Bill Ackman's Latest Moves In Health Care & Some Other Positions From Q1 | https://www.benzinga.com/trading-ideas/long-ideas/15/05/5516556/bill-ackmans-latest-moves-in-health-care-some-other-positions | Santhosh Naikar | 2015-05-16T00:00:00 | ZTS |
1,412,455 | Affymetrix Acquires Assets of Eureka Genomics Corporation for $15M in Cash | https://www.benzinga.com/news/15/05/5509504/affymetrix-acquires-assets-of-eureka-genomics-corporation-for-15m-in-cash | Charles Gross | 2015-05-14T00:00:00 | ZTS |
1,412,456 | From Conf Call: Zoetis CEO Says Co to Cut 2000-2500 Jobs in Next 18 Months | https://www.benzinga.com/news/earnings/15/05/5476858/from-conf-call-zoetis-ceo-says-co-to-cut-2000-2500-jobs-in-next-18-month | Charles Gross | 2015-05-05T00:00:00 | ZTS |
1,412,457 | Zoetis Posts Upbeat Q1 Earnings, But Lowers FY15 Forecast | https://www.benzinga.com/news/earnings/15/05/5476795/zoetis-posts-upbeat-q1-earnings-but-lowers-fy15-forecast | Lisa Levin | 2015-05-05T00:00:00 | ZTS |
1,412,458 | From Conf Call: Zoetis CFO Says Shares Buybacks Will Continue to be Part of Co's Plans | https://www.benzinga.com/news/earnings/15/05/5476794/from-conf-call-zoetis-cfo-says-shares-buybacks-will-continue-to-be-part- | Charles Gross | 2015-05-05T00:00:00 | ZTS |
1,412,459 | From Zoetis Q1 Earnings Conference Call: Expecting to Reduce Headcount by 2-2.5K Employees Over the Next Year to Year and a Half | https://www.benzinga.com/news/15/05/5476422/from-zoetis-q1-earnings-conference-call-expecting-to-reduce-headcount-by-2-2-5k-e | Paul Quintaro | 2015-05-05T00:00:00 | ZTS |
1,412,460 | Zoetis Sees FY17 Adj. EPS $2.18-$2.32, Sales $4.85B-$5.05B | https://www.benzinga.com/news/15/05/5475555/zoetis-sees-fy17-adj-eps-2-18-2-32-sales-4-85b-5-05b | Paul Quintaro | 2015-05-05T00:00:00 | ZTS |
1,412,461 | Zoetis Reports Q1 EPS $0.33 Vs Est $0.37, Sales $1.1B Vs Est $1.11B | https://www.benzinga.com/news/earnings/15/05/5475421/zoetis-reports-q1-eps-0-33-vs-est-0-37-sales-1-1b-vs-est-1-11b | Eddie Staley | 2015-05-05T00:00:00 | ZTS |
1,412,462 | Earning & Economic Calendar for Tuesday May 5, 2015 | https://www.benzinga.com/news/earnings/15/05/5475106/earning-economic-calendar-for-tuesday-may-5-2015 | Charles Gross | 2015-05-05T00:00:00 | ZTS |
1,412,463 | Bill Ackman Next Speaker at Sohn Conference | https://www.benzinga.com/news/15/05/5474183/bill-ackman-next-speaker-at-sohn-conference | Charles Gross | 2015-05-04T00:00:00 | ZTS |
1,412,464 | No Growth For Zoetis; Analysts Expect Flat YOY Earnings | https://www.benzinga.com/analyst-ratings/analyst-color/15/05/5472758/no-growth-for-zoetis-analysts-expect-flat-yoy-earnings | Javier Hasse | 2015-05-04T00:00:00 | ZTS |
1,412,465 | Shares of Zoetis Volatile Here as Bill Ackman Recently Discussing on CNBC in Interview with Scott Wapner, Josh Brown | https://www.benzinga.com/news/15/05/5472648/shares-of-zoetis-volatile-here-as-bill-ackman-recently-discussing-on-cnbc-in-inte | Paul Quintaro | 2015-05-04T00:00:00 | ZTS |
1,412,466 | Ira Sohn Conference Live Blog: Movers, Shakers, Hedgie Comments | https://www.benzinga.com/news/15/05/5472619/ira-sohn-conference-live-blog-movers-shakers-hedgie-comments | Jake Mann | 2015-05-04T00:00:00 | ZTS |
1,412,467 | Pennsylvania DEP Awards $2.05M in West Nile Virus Grants to 25 Counties -Reuters | https://www.benzinga.com/news/15/05/5467417/pennsylvania-dep-awards-2-05m-in-west-nile-virus-grants-to-25-counties-reuters | Charles Gross | 2015-05-01T00:00:00 | ZTS |
1,412,468 | Option Alert: Zoetis October $48 Call; 1786 Contract Trade at Ask @$3.20 | https://www.benzinga.com/markets/options/15/04/5423545/option-alert-zoetis-october-48-call-1786-contract-trade-at-ask-3-20 | Charles Gross | 2015-04-20T00:00:00 | ZTS |
1,412,469 | Activist Investors And Insider Buying: A Strong Signal | https://www.benzinga.com/trading-ideas/long-ideas/15/04/5419012/activist-investors-and-insider-buying-a-strong-signal | David Miller | 2015-04-17T00:00:00 | ZTS |
1,412,470 | Canine Flu Outbreak Reported in Chicago Area -Wall Street Journal | https://www.benzinga.com/news/15/04/5410955/canine-flu-outbreak-reported-in-chicago-area-wall-street-journal | Charles Gross | 2015-04-15T00:00:00 | ZTS |
1,412,471 | UPDATE: Filing from Pershing Square on Zoetis Shows Very Slightly Increased Stake in Zoetis from 8.35% as of Feb. 3 to 8.4% | https://www.benzinga.com/news/15/04/5403369/update-filing-from-pershing-square-on-zoetis-shows-very-slightly-increased-stake- | Paul Quintaro | 2015-04-13T00:00:00 | ZTS |
1,412,472 | Amended 13D Filing from Bill Ackman's Pershing Square on Zoetis Just Out | https://www.benzinga.com/news/15/04/5403357/amended-13d-filing-from-bill-ackmans-pershing-square-on-zoetis-just-out | Paul Quintaro | 2015-04-13T00:00:00 | ZTS |
1,412,473 | Earlier Filing from Zoetis Shows Actavis Chair Paul Bisaro Named to Board; Shares Trading Up ~$0.70 | https://www.benzinga.com/news/15/04/5401750/earlier-filing-from-zoetis-shows-actavis-chair-paul-bisaro-named-to-board-shares- | Paul Quintaro | 2015-04-13T00:00:00 | ZTS |
1,412,474 | Option Alert: Zoetis Apr $48 Call; 2000 Contract Trade Above Ask @$0.74; $46.89 | https://www.benzinga.com/news/15/03/5356505/option-alert-zoetis-apr-48-call-2000-contract-trade-above-ask-0-74 | Charles Gross | 2015-03-25T00:00:00 | ZTS |
1,412,475 | Books on Valeant's $9.6B High Yield Bond Near $29B, According to Source -Reuters | https://www.benzinga.com/news/15/03/5322241/books-on-valeants-9-6b-high-yield-bond-near-29b-according-to-source-reuters | Charles Gross | 2015-03-12T00:00:00 | ZTS |
1,412,476 | 8 Healthcare Names Cowen & Co Are Talking About | https://www.benzinga.com/analyst-ratings/analyst-color/15/03/5315206/8-healthcare-names-cowen-co-are-talking-about | Monica Gerson | 2015-03-10T00:00:00 | ZTS |
1,412,477 | Pershing Square Buys 5% Stake In Valeant Pharmaceuticals -Reuters | https://www.benzinga.com/news/15/03/5309560/pershing-square-buys-5-stake-in-valeant-pharmaceuticals-reuters | Charles Gross | 2015-03-09T00:00:00 | ZTS |
1,412,478 | The Zoetis Catalyst Schedule Wall Street Is Watching | https://www.benzinga.com/analyst-ratings/analyst-color/15/02/5271258/the-zoetis-catalyst-schedule-wall-street-is-watching | Monica Gerson | 2015-02-24T00:00:00 | ZTS |
1,412,479 | Evercore ISI Technical Analysis: The 'Single Best Idea' | https://www.benzinga.com/analyst-ratings/analyst-color/15/02/5263279/evercore-isi-technical-analysis-the-single-best-idea | Mark Meadows | 2015-02-23T00:00:00 | ZTS |
1,412,480 | ValueWalk On What Might Be Pershing Square's 'Big Secret Short' | https://www.benzinga.com/news/15/02/5257496/valuewalk-on-what-might-be-pershing-squares-big-secret-short | Kevin Riley | 2015-02-19T00:00:00 | ZTS |
1,412,481 | Actavis, NRG Energy, Wal-Mart, Zoetis, Best Buy, Mentioned by ValueWalk as Potential Ackman Shorts | https://www.benzinga.com/news/15/02/5256920/actavis-nrg-energy-wal-mart-zoetis-best-buy-mentioned-by-valuewalk-as-potential-a | Charles Gross | 2015-02-19T00:00:00 | ZTS |
1,412,482 | What Steven Cohen Is Doing With His Personal Wealth | https://www.benzinga.com/trading-ideas/long-ideas/15/02/5251941/what-steven-cohen-is-doing-with-his-personal-wealth | Javier Hasse | 2015-02-18T00:00:00 | ZTS |
1,412,483 | Ackman's Pershing Square Scaled Back Allergan, Added To Platform Specialty Products In Q4 | https://www.benzinga.com/trading-ideas/long-ideas/15/02/5248913/ackmans-pershing-square-scaled-back-allergan-added-to-platfor | Wayne Duggan | 2015-02-17T00:00:00 | ZTS |
1,412,484 | CORRECTION: 13F Filing from Ackman's Pershing Shows Less Recent Stake in Zoetis Compared to Feb. 4th Filing; More Recent Filing Shows Stake of ~41.82M Shares | https://www.benzinga.com/news/15/02/5248638/correction-13f-filing-from-ackmans-pershing-shows-less-recent-stake-in-zoetis-com | Paul Quintaro | 2015-02-17T00:00:00 | ZTS |
1,412,485 | Bill Ackman Thinks Valeant Is 'Incredibly Disciplined,' And Says He'd Own McDonald's If 3G Capital Was In Charge | https://www.benzinga.com/trading-ideas/long-ideas/15/02/5240155/bill-ackman-thinks-valeant-is-incredibly-disciplined-and-says | Ritesh Anan | 2015-02-13T00:00:00 | ZTS |
1,412,486 | JP Morgan Downgrades Zoetis to Neutral, Maintains $48.00 PT | https://www.benzinga.com/news/15/02/5239607/jp-morgan-downgrades-zoetis-to-neutral-maintains-48-00-pt | Paul Quintaro | 2015-02-13T00:00:00 | ZTS |
1,412,487 | Zoetis Flexes Muscles; Has "Pipeline Power," Says Barclays | https://www.benzinga.com/analyst-ratings/analyst-color/15/02/5236473/zoetis-flexes-muscles-has-pipeline-power-says-barclays | Anthony Sanfilippo | 2015-02-12T00:00:00 | ZTS |
1,412,488 | Stocks Hitting 52-Week Highs | https://www.benzinga.com/news/15/02/5231664/stocks-hitting-52-week-highs | Lisa Levin | 2015-02-11T00:00:00 | ZTS |
1,412,489 | Morning Market Gainers | https://www.benzinga.com/news/15/02/5231625/morning-market-gainers | Lisa Levin | 2015-02-11T00:00:00 | ZTS |
1,412,490 | UPDATE: Zoetis Shares Rise On Upbeat Earnings | https://www.benzinga.com/news/earnings/15/02/5230971/update-zoetis-shares-rise-on-upbeat-earnings | Monica Gerson | 2015-02-11T00:00:00 | ZTS |
1,412,491 | Zoetis Reports Q4 Adj. EPS $0.40 vs $0.36 Est., Sales $1.32B vs $1.27B Est.; Sees FY Adj. EPS $1.61-$1.68, Sales $4.8B-4.9B | https://www.benzinga.com/news/earnings/15/02/5230547/zoetis-reports-q4-adj-eps-0-40-vs-0-36-est-sales-1-32b-vs-1-27b-est-sees | Paul Quintaro | 2015-02-11T00:00:00 | ZTS |
1,412,492 | Earnings Scheduled For February 11, 2015 | https://www.benzinga.com/news/earnings/15/02/5230245/earnings-scheduled-for-february-11-2015 | Monica Gerson | 2015-02-11T00:00:00 | ZTS |
1,412,493 | UPDATE: Zoetis Names William Doyle to Board | https://www.benzinga.com/news/15/02/5209269/update-zoetis-names-william-doyle-to-board | Eddie Staley | 2015-02-04T00:00:00 | ZTS |
1,412,494 | Zoetis Names William Doyle to Board | https://www.benzinga.com/news/15/02/5209265/zoetis-names-william-doyle-to-board | Paul Quintaro | 2015-02-04T00:00:00 | ZTS |
1,412,495 | Hearing Bill Ackman to Win Zoetis Board Seats | https://www.benzinga.com/news/15/01/5192142/hearing-bill-ackman-to-win-zoetis-board-seats | Charles Gross | 2015-01-29T00:00:00 | ZTS |
1,412,496 | Ken Squire Shares His Activist Trades | https://www.benzinga.com/media/cnbc/15/01/5167152/ken-squire-shares-his-activist-trades | Craig Jones | 2015-01-21T00:00:00 | ZTS |
1,412,497 | Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 3 | https://www.benzinga.com/trading-ideas/long-ideas/15/01/5136467/biotechs-presenting-at-the-j-p-morgan-healthcare-conference-d | Kyle Dennis | 2015-01-13T00:00:00 | ZTS |
1,412,498 | Zoetis CEO Says Open to Inversion Deal -Wall Street Journal | https://www.benzinga.com/news/15/01/5142888/zoetis-ceo-says-open-to-inversion-deal-wall-street-journal | Charles Gross | 2015-01-13T00:00:00 | ZTS |
1,412,499 | Top 4 Small-Cap Stocks In The Drugs-Generic Industry With The Lowest PEG Ratio | https://www.benzinga.com/trading-ideas/14/12/5089972/top-4-small-cap-stocks-in-the-drugs-generic-industry-with-the-lowest-peg | Monica Gerson | 2014-12-18T00:00:00 | ZTS |
1,412,500 | Zoetis Increases Qtr Dividend From $0.072 To $0.083/share | https://www.benzinga.com/news/14/12/5089043/zoetis-increases-qtr-dividend-from-0-072-to-0-083share | Hal Lindon | 2014-12-17T00:00:00 | ZTS |
1,412,501 | Ackman Declines Comment on Zoetis Investment, Says 'Too Early to Discuss' | https://www.benzinga.com/news/14/12/5087900/ackman-declines-comment-on-zoetis-investment-says-too-early-to-discuss | Paul Quintaro | 2014-12-17T00:00:00 | ZTS |
1,412,502 | Cramer Comments On Alibaba, Zoetis | https://www.benzinga.com/media/cnbc/14/12/5082249/cramer-comments-on-alibaba-zoetis | Craig Jones | 2014-12-16T00:00:00 | ZTS |
1,412,503 | Benzinga's Top Initiations | https://www.benzinga.com/analyst-ratings/initiation/14/12/5073853/benzingas-top-initiations | Lisa Levin | 2014-12-11T00:00:00 | ZTS |
1,412,504 | Cowen Initiates Zoetis With Market Perform | https://www.benzinga.com/analyst-ratings/initiation/14/12/5073735/cowen-initiates-zoetis-with-market-perform | Monica Gerson | 2014-12-11T00:00:00 | ZTS |
1,412,505 | Cowen & Company Initiates Coverage on Zoetis at Market Perform, Announces $47.00 PT | https://www.benzinga.com/news/14/12/5073113/cowen-amp-company-initiates-coverage-on-zoetis-at-market-perform-announces-47-00- | Paul Quintaro | 2014-12-11T00:00:00 | ZTS |
1,412,506 | Zoetis Inc. Spikes Briefly On Remarks From Sanofi CEO | https://www.benzinga.com/news/14/12/5068374/zoetis-inc-spikes-briefly-on-remarks-from-sanofi-ceo | John Seward | 2014-12-09T00:00:00 | ZTS |
1,412,507 | Zoetis Declines Comment on Talks with Sanofi | https://www.benzinga.com/news/14/12/5067998/zoetis-declines-comment-on-talks-with-sanofi | Charles Gross | 2014-12-09T00:00:00 | ZTS |
1,412,508 | Zoetis Falling Back From $44.49 High, Currently At $43.47 | https://www.benzinga.com/news/14/12/5067819/zoetis-falling-back-from-44-49-high-currently-at-43-47 | Paul Quintaro | 2014-12-09T00:00:00 | ZTS |
1,412,509 | Zoetis Shares Spike Higher; Calls Trading At Roughly 30 Times Normal Volume | https://www.benzinga.com/markets/options/14/12/5067803/zoetis-shares-spike-higher-calls-trading-at-roughly-30-times-normal-vo | Hal Lindon | 2014-12-09T00:00:00 | ZTS |
1,412,510 | Sanofi's Weinberg Says Ready To Make Acquisitions In Vet Medicine | https://www.benzinga.com/news/14/12/5067778/sanofis-weinberg-says-ready-to-make-acquisitions-in-vet-medicine | Paul Quintaro | 2014-12-09T00:00:00 | ZTS |
1,412,511 | Zoetis Spikes Higher; May be Attributed to Comments from Sanofi | https://www.benzinga.com/news/14/12/5067774/zoetis-spikes-higher-may-be-attributed-to-comments-from-sanofi | Charles Gross | 2014-12-09T00:00:00 | ZTS |
1,412,512 | Zoetis Spikes Higher | https://www.benzinga.com/news/14/12/5067772/zoetis-spikes-higher | Charles Gross | 2014-12-09T00:00:00 | ZTS |
1,412,513 | Top 4 NYSE Stocks In The Drugs-Generic Industry With The Highest Profit Margin | https://www.benzinga.com/trading-ideas/14/12/5066005/top-4-nyse-stocks-in-the-drugs-generic-industry-with-the-highest-profit- | Monica Gerson | 2014-12-09T00:00:00 | ZTS |
1,412,514 | UPDATE: Pershing Had Shown Stake of 1.1% as of Nov. 11, 2014 on Zoetis | https://www.benzinga.com/news/14/12/5061496/update-pershing-had-shown-stake-of-1-1-as-of-nov-11-2014-on-zoetis | Paul Quintaro | 2014-12-05T00:00:00 | ZTS |
1,412,515 | UPDATE: Filing from Ackman's Pershing on Zoetis Shows 8.3% Stake | https://www.benzinga.com/news/14/12/5061486/update-filing-from-ackmans-pershing-on-zoetis-shows-8-3-stake | Paul Quintaro | 2014-12-05T00:00:00 | ZTS |
1,412,516 | Amended 13D Filing from Ackman's Pershing Square on Zoetis Just Filed | https://www.benzinga.com/news/14/12/5061483/amended-13d-filing-from-ackmans-pershing-square-on-zoetis-just-filed | Paul Quintaro | 2014-12-05T00:00:00 | ZTS |
1,412,517 | Jefferies Raises Zoetis Price Target, Says Consolidation Continues To Look Likely | https://www.benzinga.com/analyst-ratings/analyst-color/14/11/5039786/jefferies-raises-zoetis-price-target-says-consolidation- | Jayson Derrick | 2014-11-26T00:00:00 | ZTS |
1,412,518 | Jefferies Maintains Buy on Zoetis, Raises PT to $53.00 | https://www.benzinga.com/news/14/11/5039555/jefferies-maintains-buy-on-zoetis-raises-pt-to-53-00 | James Hunt | 2014-11-26T00:00:00 | ZTS |
1,412,519 | Zoetis Announces Appointment Of Roman Trawicki As President Of Global Manufacturing And Supply | https://www.benzinga.com/news/14/11/5032971/zoetis-announces-appointment-of-roman-trawicki-as-president-of-global-manufacturi | Eddie Staley | 2014-11-24T00:00:00 | ZTS |
1,412,520 | UPDATE: Bank Of America Reiterates On Zoetis On Enhanced Clarity On Long-Term Prospects | https://www.benzinga.com/analyst-ratings/analyst-color/14/11/5022703/update-bank-of-america-reiterates-on-zoetis-on-enhanced- | Dwight Einhorn | 2014-11-19T00:00:00 | ZTS |